Floatz logo

Letrozole

Peritoneal Carcinoma

Ronald BuckanovichSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Peritoneal Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
CanariaBio Inc.
Phase 3BB
Irinotecan
University of Utah
Phase 2B
STAPULDENCEL
SOTIO a.s.
Phase 3B
Dcvac/Ovca
SOTIO a.s.
Phase 3B
Eloxatin
University of Utah
Phase 2B

View all 27 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →